We are live on
!
Find out more
AC
Aristides Capital Portfolio holdings
AUM
$462M
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+11.36%
1 Year Est. Return
+28.94%
3 Year Est. Return
+109.78%
5 Year Est. Return
+150.66%
10 Year Est. Return
–
AUM
$488M
AUM Growth
+$166M
(+52%)
Cap. Flow
+$110M
Cap. Flow
% of AUM
22.59%
Top 10 Holdings %
Top 10 Hldgs %
49.86%
Holding
365
New
127
Increased
137
Reduced
21
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$19.4M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$7.17M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$6.68M |
| 4 |
TYG
Tortoise Energy Infrastructure Corp
TYG
|
+$6.4M |
| 5 |
TPZ
Tortoise Electrification Infrastructure ETF
TPZ
|
+$5.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.83M |
| 2 |
NTG
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
|
+$5.01M |
| 3 |
Turning Point Brands
TPB
|
+$3.26M |
| 4 |
Capri Holdings
CPRI
|
+$2.95M |
| 5 |
TTP
TORTOISE PIPELINE & ENERGY FUND, INC.
TTP
|
+$2.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.51% |
| 2 | Industrials | 6.26% |
| 3 | Financials | 6.12% |
| 4 | Consumer Discretionary | 5.78% |
| 5 | Communication Services | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Perspective Therapeutics
CATX
$327M
| $187K | 0.04% |
+58,700
| New | +$479K |
|
252
Regenxbio
RGNX
$615M
| $187K | 0.04% |
+24,200
| New | +$227K |
|
253
Viasat
VSAT
$10.2B
| $186K | 0.04% |
+21,800
| New | +$210K |
|
254
StoneCo
STNE
$2.71B
| $184K | 0.04% |
+23,100
| New | +$234K |
|
|
NKLA
255
DELISTED
Nikola Corporation Common Stock
NKLA
| $182K | 0.04% |
+153,275
| New | +$438K |
|
256
Intellia Therapeutics
NTLA
$1.52B
| $182K | 0.04% |
+15,600
| New | +$243K |
|
|
PCN
257
PIMCO Corporate & Income Strategy Fund
PCN
$870M
| $180K | 0.04% |
+13,420
| New | +$186K |
|
258
Relay Therapeutics
RLAY
$3.99B
| $179K | 0.04% |
+43,400
| New | +$236K |
|
|
NOVA
259
DELISTED
Sunnova Energy
NOVA
| $177K | 0.04% |
+51,500
| New | +$258K |
|
|
LAZR
260
DELISTED
Luminar Technologies
LAZR
| $176K | 0.04% |
+32,800
| New | +$347K |
|
261
Cabaletta Bio
CABA
$445M
| $171K | 0.04% |
+75,400
| New | +$265K |
|
262
FuelCell Energy
FCEL
$1.57B
| $170K | 0.03% |
+18,800
| New | +$186K |
|
263
AnaptysBio
ANAB
$1.54B
| $168K | 0.03% |
+12,700
| New | +$308K |
|
264
Editas Medicine
EDIT
$402M
| $168K | 0.03% |
+131,900
| New | +$336K |
|
265
Fate Therapeutics
FATE
$270M
| $166K | 0.03% |
+100,555
| New | +$253K |
|
266
Granite Ridge Resources
GRNT
$601M
| $166K | 0.03% |
25,650
-768
| -3% | -$4.75K |
|
267
Stoneridge
SRI
$208M
| $164K | 0.03% |
+26,100
| New | +$200K |
|
268
Crawford & Co Class B
CRD.B
$502M
| $160K | 0.03% |
13,785
-3,009
| -18% | -$34K |
|
269
Barnes & Noble Education
BNED
$451M
| $155K | 0.03% |
+15,400
| New | +$158K |
|
270
Safe Bulkers
SB
$761M
| $151K | 0.03% |
+42,240
| New | +$176K |
|
271
Cato Corp
CATO
$67.3M
| $149K | 0.03% |
38,226
+2,165
| +6% | +$10.6K |
|
|
GHY
272
PGIM Global High Yield Fund
GHY
$480M
| $149K | 0.03% |
+12,090
| New | +$154K |
|
273
Accel Entertainment
ACEL
$1.01B
| $148K | 0.03% |
13,893
-5,856
| -30% | -$66.9K |
|
|
FLNA
274
Filana Therapeutics
FLNA
$42.7M
| $148K | 0.03% |
+62,542
| New | +$1.1M |
|
275
Chegg
CHGG
$121M
| $147K | 0.03% |
+91,400
| New | +$168K |
|
Similar funds
PRCP
PC
GLAM
NG
SHWM
CPIM
HSA
CWWM
Aristides Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Aristides Capital held 365 positions worth $488M, up 52% from $322M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Aristides Capital deployed $110M of net new capital in Q4 2024, opening 127 new positions and adding to 137 existing holdings. Its largest new stake was iShares Core S&P Small-Cap ETF: 60,000 shares worth $6.91M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $8.83M trimmed.
- Aristides Capital's largest Q4 2024 buy was iShares Core S&P Small-Cap ETF: 60,000 shares worth $6.91M.
- Aristides Capital added most to iShares Bitcoin Trust in Q4 2024, an estimated $19.4M increase.
- Aristides Capital's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $8.83M.
- Aristides Capital fully exited Tortoise Midstream Energy Fund, Inc. Common Stock in Q4 2024, selling an estimated $5.01M.
- Aristides Capital's ten largest holdings make up 50% of its $488M portfolio in Q4 2024.
- Aristides Capital opened 127 new positions and closed 62 in Q4 2024.
- Aristides Capital's portfolio value rose 52% quarter-over-quarter to $488M.
Based on Aristides Capital's 13F filing for Q4 2024, filed 13 Feb 2025.